Company: INSP
Filing Date: 2025-05-05
Form Type: 10-Q
Source: 0001609550-25-000020
Chunk: 62

Company: Inspire Medical Systems, Inc.
Filing Date: 2025-05-05
Form: 10-Q
Item: Part I, Item 8
Chunk 62
---
Commercial paper$19,806 $25 $— $19,831 Corporate debt securities47,226 80 (7)47,299 Certificates of deposit7,684 10 — 7,694 U.S. treasury debt securities220,283 346 (57)220,572 Short-term investments$294,999 $461 $(64)$295,396 Long-Term:Corporate debt securities$23,915 $59 $(49)$23,925 Asset-backed securities287 — — 287 U.S. treasury debt securities46,818 50 (85)46,783 Long-term investments$71,020 $109 $(134)$70,995 The following table shows all available-for-sale investments in an unrealized loss position for which an allowance for credit losses has not been recorded and the related gross unrealized loss and fair value, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position:

10

Table of ContentsInspire Medical Systems, Inc. Notes to Consolidated Financial Statements (unaudited) (Table amounts in thousands, except share and per share amounts)

March 31, 2025Less than 12 Months12 Months or GreaterTotalFair ValueUnrealized LossFair ValueUnrealized LossFair ValueUnrealized LossCorporate debt securities$10,593 $(20)$— $— $10,593 $(20)U.S. Treasury debt securities69,029 (99)— — 69,029 (99)Total$79,622 $(119)$— $— $79,622 $(119)December 31, 2024Less than 12 Months12 Months or GreaterTotalFair ValueUnrealized LossFair ValueUnrealized LossFair ValueUnrealized LossCorporate debt securities$11,728 $(56)$— $— $11,728 $(56)U.S. Treasury debt securities69,402 (220)— — 69,402 (220)Total$81,130 $(276)$— $— $81,130 $(276)Investments are classified as available-for-sale and are reported at their estimated fair market values which are based on quoted, active or inactive market prices when available. Any unrealized gains and losses due to interest rate fluctuations and other external factors are reported as a separate component of